RELB and central nervous system cancer: Analysis of patients data from the Cancer Genome Atlas (TCGA) and the Chinese Glioma Genome Atlas (CGGA) indicates that increased RelB expression correlates with more severe glioma grade, shorter life expectancy, and overall negative prognosis [205,206].